William A. Curran

Davis Polk is advising certain holders of senior unsecured notes in connection with a restructuring of Ferrellgas Partners, L.P. (“MLP”) and its subsidiaries. On December 10, 2020…

Davis Polk advised Freeport-McMoRan Inc. in connection with its $550 million sale of its interests in the Kisanfu project to a wholly owned subsidiary of China Molybdenum Co., Ltd. The…

Davis Polk is advising an ad hoc group of noteholders (the “Ad Hoc Group”) holding approximately 74% of the face amount of Superior Energy Services, Inc.’s (together with certain of its…

Davis Polk is advising Silver Spike Acquisition Corp., a publicly-traded SPAC, in connection with its business combination with WM Holding Company, LLC that would result in WMH becoming a…

Davis Polk advised XP Inc. on its $1.23 billion equity offering of 31,654,894 Class A common shares, consisting of 7,130,435 shares sold by XP and 24,524,459 shares sold by ITB Holding…

Davis Polk advised Jiya Acquisition Corp. on its $100 million initial public offering of 10,000,000 shares of Class A common stock. The shares are listed on the Nasdaq Capital Market. …

Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective provider payment capabilities for episodes of care, supporting the…

Davis Polk advised Auna S.A.A. in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 6.500% senior notes due 2025. The notes are…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered public debt offering by Bristol-Myers Squibb Company,…

Davis Polk is advising Novo Nordisk A/S on its $1.8 billion acquisition of Emisphere Technologies Inc. and related Eligen SNAC royalty stream obligations owed to MHR Fund Management LLC,…